Skip to content

WHWK WHWK Total debt

Discontinued — last reported Q4 '24

Total debt at other companies

IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$28.6M+10.1%
Eli Lilly logo
Eli LillyLLY
Pfizer logo
PfizerPFE
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Gilead Sciences logo
Gilead SciencesGILD
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $833K.

The official record: WHWK’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's total debt?
WHWK (WHWK) reported total debt of $833K in Q4 2024.
How has WHWK's total debt changed year-over-year?
WHWK's total debt decreased by 34.3% year-over-year, from $1.27M to $833K.
What is the long-term trend for WHWK's total debt?
Over 3 years (2021 to 2024), WHWK's total debt has grown at a 11.2% compound annual growth rate (CAGR), from $605K to $833K.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.